Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 3 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9AH23
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006370 | 7-methylguanosine mRNA capping | 8 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006397 | mRNA processing | 7 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009452 | 7-methylguanosine RNA capping | 8 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0016071 | mRNA metabolic process | 6 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0036260 | RNA capping | 7 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003746 | translation elongation factor activity | 4 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity | 6 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008135 | translation factor activity, RNA binding | 3 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008171 | O-methyltransferase activity | 5 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008174 | mRNA methyltransferase activity | 5 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0045182 | translation regulator activity | 1 | 12 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 216 | 220 | PF00656 | 0.316 |
CLV_NRD_NRD_1 | 134 | 136 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.345 |
CLV_NRD_NRD_1 | 252 | 254 | PF00675 | 0.562 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.276 |
CLV_NRD_NRD_1 | 411 | 413 | PF00675 | 0.461 |
CLV_NRD_NRD_1 | 421 | 423 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 426 | 428 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 433 | 435 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.145 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.366 |
CLV_PCSK_FUR_1 | 132 | 136 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.343 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.638 |
CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.563 |
CLV_PCSK_KEX2_1 | 411 | 413 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 426 | 428 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 432 | 434 | PF00082 | 0.531 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.315 |
CLV_PCSK_PC1ET2_1 | 244 | 246 | PF00082 | 0.610 |
CLV_PCSK_PC1ET2_1 | 432 | 434 | PF00082 | 0.537 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.288 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.346 |
CLV_PCSK_PC7_1 | 422 | 428 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 326 | 330 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 40 | 44 | PF00082 | 0.275 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.364 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.272 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.629 |
DEG_SPOP_SBC_1 | 229 | 233 | PF00917 | 0.276 |
DOC_CYCLIN_RxL_1 | 36 | 48 | PF00134 | 0.437 |
DOC_CYCLIN_yCln2_LP_2 | 312 | 318 | PF00134 | 0.328 |
DOC_CYCLIN_yCln2_LP_2 | 80 | 86 | PF00134 | 0.413 |
DOC_CYCLIN_yCln2_LP_2 | 96 | 102 | PF00134 | 0.195 |
DOC_MAPK_MEF2A_6 | 230 | 239 | PF00069 | 0.276 |
DOC_PP2B_LxvP_1 | 80 | 83 | PF13499 | 0.449 |
DOC_PP4_FxxP_1 | 190 | 193 | PF00568 | 0.276 |
DOC_PP4_FxxP_1 | 27 | 30 | PF00568 | 0.635 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.284 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.325 |
DOC_USP7_MATH_1 | 229 | 233 | PF00917 | 0.276 |
DOC_USP7_MATH_1 | 291 | 295 | PF00917 | 0.457 |
DOC_WD40_RPTOR_TOS_1 | 179 | 184 | PF00400 | 0.353 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.536 |
LIG_14-3-3_CanoR_1 | 132 | 138 | PF00244 | 0.307 |
LIG_14-3-3_CanoR_1 | 253 | 259 | PF00244 | 0.364 |
LIG_14-3-3_CanoR_1 | 326 | 331 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 382 | 387 | PF00244 | 0.226 |
LIG_14-3-3_CanoR_1 | 6 | 14 | PF00244 | 0.546 |
LIG_CaM_NSCaTE_8 | 327 | 334 | PF13499 | 0.314 |
LIG_deltaCOP1_diTrp_1 | 176 | 179 | PF00928 | 0.344 |
LIG_eIF4E_1 | 37 | 43 | PF01652 | 0.484 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.287 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.287 |
LIG_FHA_1 | 162 | 168 | PF00498 | 0.267 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.339 |
LIG_FHA_2 | 209 | 215 | PF00498 | 0.391 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.323 |
LIG_FHA_2 | 301 | 307 | PF00498 | 0.347 |
LIG_KLC1_Yacidic_2 | 214 | 219 | PF13176 | 0.381 |
LIG_LIR_Apic_2 | 24 | 30 | PF02991 | 0.634 |
LIG_LIR_Gen_1 | 213 | 223 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 391 | 400 | PF02991 | 0.468 |
LIG_LIR_Gen_1 | 93 | 102 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 213 | 218 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 309 | 313 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 391 | 395 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 87 | 92 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 93 | 97 | PF02991 | 0.312 |
LIG_PCNA_TLS_4 | 280 | 287 | PF02747 | 0.389 |
LIG_Pex14_2 | 383 | 387 | PF04695 | 0.391 |
LIG_SH2_CRK | 247 | 251 | PF00017 | 0.411 |
LIG_SH2_CRK | 255 | 259 | PF00017 | 0.392 |
LIG_SH2_CRK | 396 | 400 | PF00017 | 0.344 |
LIG_SH2_GRB2like | 18 | 21 | PF00017 | 0.655 |
LIG_SH2_NCK_1 | 247 | 251 | PF00017 | 0.432 |
LIG_SH2_SRC | 217 | 220 | PF00017 | 0.349 |
LIG_SH2_STAT3 | 205 | 208 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 255 | 258 | PF00017 | 0.345 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 342 | 345 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 396 | 399 | PF00017 | 0.449 |
LIG_SH3_1 | 189 | 195 | PF00018 | 0.276 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.657 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.276 |
LIG_SH3_3 | 223 | 229 | PF00018 | 0.283 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.259 |
LIG_SH3_3 | 312 | 318 | PF00018 | 0.334 |
LIG_SUMO_SIM_par_1 | 115 | 123 | PF11976 | 0.278 |
LIG_TRAF2_1 | 136 | 139 | PF00917 | 0.228 |
LIG_TRAF2_1 | 211 | 214 | PF00917 | 0.381 |
LIG_TRFH_1 | 86 | 90 | PF08558 | 0.449 |
LIG_TYR_ITIM | 340 | 345 | PF00017 | 0.424 |
MOD_CDC14_SPxK_1 | 65 | 68 | PF00782 | 0.456 |
MOD_CDK_SPK_2 | 62 | 67 | PF00069 | 0.536 |
MOD_CDK_SPxK_1 | 62 | 68 | PF00069 | 0.536 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.603 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.507 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.362 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.352 |
MOD_CK2_1 | 228 | 234 | PF00069 | 0.276 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.321 |
MOD_CK2_1 | 300 | 306 | PF00069 | 0.337 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.476 |
MOD_Cter_Amidation | 420 | 423 | PF01082 | 0.587 |
MOD_Cter_Amidation | 429 | 432 | PF01082 | 0.594 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.476 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.580 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.341 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.375 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.305 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.240 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.325 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.321 |
MOD_LATS_1 | 324 | 330 | PF00433 | 0.385 |
MOD_N-GLC_1 | 20 | 25 | PF02516 | 0.483 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.362 |
MOD_NEK2_1 | 300 | 305 | PF00069 | 0.351 |
MOD_NEK2_1 | 330 | 335 | PF00069 | 0.312 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.445 |
MOD_NEK2_2 | 254 | 259 | PF00069 | 0.334 |
MOD_PIKK_1 | 218 | 224 | PF00454 | 0.381 |
MOD_PK_1 | 382 | 388 | PF00069 | 0.300 |
MOD_PKA_1 | 59 | 65 | PF00069 | 0.470 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.307 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.549 |
MOD_Plk_1 | 208 | 214 | PF00069 | 0.389 |
MOD_Plk_2-3 | 213 | 219 | PF00069 | 0.381 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.365 |
MOD_Plk_4 | 282 | 288 | PF00069 | 0.352 |
MOD_Plk_4 | 326 | 332 | PF00069 | 0.308 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.536 |
MOD_SUMO_rev_2 | 376 | 381 | PF00179 | 0.264 |
TRG_DiLeu_BaEn_1 | 46 | 51 | PF01217 | 0.525 |
TRG_DiLeu_BaEn_4 | 213 | 219 | PF01217 | 0.381 |
TRG_DiLeu_BaLyEn_6 | 233 | 238 | PF01217 | 0.347 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.632 |
TRG_DiLeu_BaLyEn_6 | 277 | 282 | PF01217 | 0.409 |
TRG_DiLeu_BaLyEn_6 | 80 | 85 | PF01217 | 0.433 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.394 |
TRG_ENDOCYTIC_2 | 310 | 313 | PF00928 | 0.421 |
TRG_ENDOCYTIC_2 | 342 | 345 | PF00928 | 0.423 |
TRG_ENDOCYTIC_2 | 349 | 352 | PF00928 | 0.325 |
TRG_ER_diArg_1 | 131 | 134 | PF00400 | 0.362 |
TRG_ER_diArg_1 | 14 | 16 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 252 | 254 | PF00400 | 0.383 |
TRG_ER_diArg_1 | 426 | 428 | PF00400 | 0.799 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.562 |
TRG_NLS_Bipartite_1 | 40 | 62 | PF00514 | 0.539 |
TRG_NLS_Bipartite_1 | 422 | 436 | PF00514 | 0.768 |
TRG_NLS_MonoCore_2 | 430 | 435 | PF00514 | 0.635 |
TRG_NLS_MonoExtN_4 | 431 | 436 | PF00514 | 0.736 |
TRG_Pf-PMV_PEXEL_1 | 280 | 284 | PF00026 | 0.589 |
TRG_Pf-PMV_PEXEL_1 | 302 | 306 | PF00026 | 0.570 |
TRG_Pf-PMV_PEXEL_1 | 7 | 11 | PF00026 | 0.317 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HV56 | Leptomonas seymouri | 68% | 100% |
A0A0S4J219 | Bodo saltans | 49% | 100% |
A0A1X0NIX1 | Trypanosomatidae | 49% | 100% |
A0A3S7WY48 | Leishmania donovani | 97% | 100% |
A0A422P442 | Trypanosoma rangeli | 52% | 100% |
A4HD69 | Leishmania braziliensis | 81% | 100% |
D0A6Y2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9AWK1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QAW9 | Leishmania major | 92% | 100% |
V5BRC4 | Trypanosoma cruzi | 51% | 100% |